
NSF Org: |
EEC Division of Engineering Education and Centers |
Recipient: |
|
Initial Amendment Date: | June 21, 2012 |
Latest Amendment Date: | June 21, 2012 |
Award Number: | 1230851 |
Award Instrument: | Standard Grant |
Program Manager: |
Lawrence A. Hornak
EEC Division of Engineering Education and Centers ENG Directorate for Engineering |
Start Date: | July 1, 2012 |
End Date: | December 31, 2013 (Estimated) |
Total Intended Award Amount: | $200,000.00 |
Total Awarded Amount to Date: | $200,000.00 |
Funds Obligated to Date: |
|
History of Investigator: |
|
Recipient Sponsored Research Office: |
1 SILBER WAY BOSTON MA US 02215-1703 (617)353-4365 |
Sponsor Congressional District: |
|
Primary Place of Performance: |
MA US 02215-1300 |
Primary Place of
Performance Congressional District: |
|
Unique Entity Identifier (UEI): |
|
Parent UEI: |
|
NSF Program(s): | IUCRC FUNDAMENTAL RESEARCH |
Primary Program Source: |
|
Program Reference Code(s): |
|
Program Element Code(s): |
|
Award Agency Code: | 4900 |
Fund Agency Code: | 4900 |
Assistance Listing Number(s): | 47.041 |
ABSTRACT
Program Director's Recommendation
Center for Biophotonic Sensors and Systems (CBSS)
Proposal # 1230851
Thomas Bifano
This proposal seeks funding for the Center forBiophotonic Sensors and Systems located at Boston University. Funding Requests for Fundamental Research are authorized by an NSF approved solicitation, NSF 11-570. The solicitation invites I/UCRCs to submit proposals for support of industry-defined fundamental research.
Recent developments in membrane biophysics, neurophysiology and molecular biology have provided the catalyst for the birth of a new field termed "optogenetics". Optogenetics relies on the expression of several unusual microbial rhodopsins in the neuronal membrane including channelrhodopsin (ChR) for light activating nerves and Archaerhodopsin (AR3) for light silencing nerves. There is a need to understand the molecular mechanisms of these proteins followed by bottoms-up bioengineering to circumvent current limitations. This project will focus on application of a set of powerful spectroscopic and biomolecular engineering techniques developed at Boston University (BU) and UC Davis. The project involves close collaboration with several industry partners and a team of leading experts in optogenetics and rhodopsins from BU, UC Davis, MIT, Harvard and the University of Texas.
Impact of the proposed project includes potentially transformative approaches to study brain function, treatment for brain disorders and restoring vision for retinal degenerative diseases. The deliverables from this project are: (1) Improved versions of ChR and AR3 with red-shifted visible absorbance, improved dynamics and improved voltage response, and (2) Document product requirements for optogenetic research tools and product vision. The industry support of the I/UCRC and active participation in this research program enhances the graduate educational experience by providing a pipeline for talented engineers and scientist to industry. BU's commitment to develop the academic potential of underrepresented groups in STEM fields will be further enhanced by offering industrial career options, informal mentorships and internships with the I/UCRC partners.
PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH
Note:
When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external
site maintained by the publisher. Some full text articles may not yet be available without a
charge during the embargo (administrative interval).
Some links on this page may take you to non-federal websites. Their policies may differ from
this site.
PROJECT OUTCOMES REPORT
Disclaimer
This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.
A key barrier limiting progress in neuroscience has been the lack of technology capable of controlling individual neurons in the functioning brain. It wasn't until 2005 that this problem was partially sovled by Karl Deisseroth and Ed Boyden at Stanford University who demonstrated a promising new apporach, referred to as optogenetics, for controlling nerves with light by expressing various type-1 rhodopsins, normally found in bacteria and algae, inside functioning neurons.
Specific areas where this approach can have an impact include: i) deciphering the funtion of the 200 billion neurons that make up the complex human brain wiring ; ii) restoring vision to the millions of persons in the U.S. suffering from macular degeneration and retinitis pigmentosa; iii) characterizing and ultimately correcting defective neuronal activity in a host of neurodegenerative disorders including traumatic brain injury, epilepsy, Parkinson's disease and Alzheimer's disease.
In this research project, we have developed new biophysical methods based on vibrational spectroscopy to characerize and understand the molecular mechanisms of type-1 rhodopsins used in optogenetics. One approach based on FTIR-difference spectroscopy allows small changes in a protein to be detected and characterized at the level of individual amino acid groups. The method is so sensitive that even small changes in the interaction of individual water molecules trapped in the rhodopsins can be detected. A second approach uses a confocal microscope and near infrared light to measure the vibrations of the light-absorbing chromophore, retinal, inside rhodopsins in living cells where the voltage across the cell membrane can be controlled.
These methods were applied to Archaerhodopsin-3 (AR3) found in the salt-loving archaebacterium Halorubrium sodomense. This protein functions as a light-activated protein pump and has been used recently to silence neurons so that their function in intact neural circuits can be studied. Furhtermore, a mutant of this protein has been used as a fluorescent sensor of transmembrane potential in cells. Small changes in the conformation of the AR3 protein in response to light and voltage were detected using the methods developed in this project . Similar studies were also initiated on a newly discovered channelrhodopsin known as CaChR1 from Chlamydomas augustae which can activate neurons with orange light. These studies are providing a basis to understand how optogenetic rhodopsins function and ultimately to engineer improved versions that can be used in both basic neuroscience investiations and to the treat neurodegenerative disorders.
Last Modified: 03/27/2014
Modified by: Kenneth J Rothschild
Please report errors in award information by writing to: awardsearch@nsf.gov.